Dnage to Participate in European Study on Biomarkers of Ageing
The consortium is headed by the University of Konstanz (Germany) and brings together 26 research groups from 14 European countries including universities, research centres and companies such as Nestlé Research Center and Unilever. The study includes about 4000 volunteers from different European regions, both men and women between 35 and 74 years old, making it one of the largest studies on biomarkers of ageing of its kind. This large-scale integrating project aims at identifying biomarkers of ageing, i.e. changes in body function or composition which are related to ageing. The resulting biomarkers could predict the onset of age-related diseases and may be used as diagnostic markers or as therapeutic targets.
DNage will use its proprietary, accelerated ageing animal models to discover novel biomarkers of ageing, and will recruit patients that suffer from premature ageing (in particular Cockayne Syndrome) to validate the identified biomarkers. The company has programs in the field of premature ageing syndromes, osteoporosis, neurodegeneration and metabolic diseases.
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.